Ascendis Pharma A/S (ASND)

Ascendis Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	7,572	7,125	6,824	7,635	9,007	6,642
Market Cap Growth	43.29%	4.41%	-10.63%	-15.23%	35.62%	152.21%
Enterprise Value	7,951	7,347	6,449	6,676	7,922	5,964
Last Close Price	151.17	125.95	122.13	134.53	166.78	139.12
PE Ratio	-	-13.32	-10.99	-16.89	-16.47	-26.45
PS Ratio	21.17	24.17	124.77	863.17	1059.02	442.49
PB Ratio	-33.57	-44.24	24.25	7.60	8.78	9.91
P/FCF Ratio	-18.88	-13.72	-12.51	-15.21	-25.27	-32.68
P/OCF Ratio	-18.95	-13.79	-12.88	-16.08	-27.12	-33.64
EV/Sales Ratio	22.23	24.92	117.92	754.73	931.41	397.32
EV/EBITDA Ratio	-23.26	-14.80	-10.85	-13.44	-20.16	-23.59
EV/EBIT Ratio	-22.84	-14.59	-10.74	-12.99	-19.59	-23.44
EV/FCF Ratio	-19.47	-14.15	-11.83	-13.30	-22.22	-29.34
Debt / Equity Ratio	-2.81	-4.42	1.93	0.12	0.11	0.06
Debt / FCF Ratio	-1.58	-1.37	-1.00	-0.24	-0.32	-0.20
Asset Turnover	0.37	0.28	0.05	0.01	0.01	0.03
Inventory Turnover	0.25	0.26	0.12	-	-	-
Quick Ratio	0.49	2.31	4.44	7.03	13.75	12.58
Current Ratio	0.83	3.56	5.39	8.03	14.02	12.74
Return on Equity (ROE)	-	-818.43%	-101.69%	-44.54%	-58.36%	-49.71%
Return on Assets (ROA)	-25.51%	-29.73%	-32.29%	-27.35%	-24.95%	-28.46%
Return on Capital (ROIC)	-40.90%	-44.83%	-39.89%	-29.42%	-26.42%	-31.01%
Earnings Yield	-7.20%	-7.47%	-9.13%	-5.71%	-5.69%	-3.68%
FCF Yield	-6.07%	-7.29%	-7.99%	-6.57%	-3.96%	-3.06%
Buyback Yield / Dilution	-1.41%	-0.38%	-2.37%	-8.21%	-8.84%	-13.20%
Total Shareholder Return	-1.41%	-0.38%	-2.37%	-8.21%	-8.84%	-13.20%

Source: S&P Capital IQ. Standard template.